All patients were pathologically diagnosed with ER+HER2− stage I–II IDC or DCIS, according to the BC biologic subtype and TNM anatomic stage classification from AJCC UICC (8th edition). This evidence concerns the gene ESR1 and ductal breast carcinoma in situ.